Xin Sun
Director/Board Member chez SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.
Profil
Xin Sun is currently serving as the Chairman-Supervisory Board at Scivita Medical Technology Co., Ltd., as well as a Non-Executive Director at Shanghai MicroPort MedBot (Group) Co., Ltd.
and MicroPort Cardiac Rhythm Management International Ltd.
Previously, Mr. Sun held the position of Non-Executive Director at Luye Pharma Group Ltd.
from 2021 to 2023.
Additionally, Mr. Sun worked at Affinity Equity Partners (HK) Ltd.
as a Vice President.
Mr. Sun completed their undergraduate degree at The Trustees of Columbia University in The City of New York in 2013, followed by a graduate degree from Duke University in 2006.
They also obtained an undergraduate degree from Peking University in 2003.
Postes actifs de Xin Sun
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Director/Board Member | 17/09/2020 |
Scivita Medical Technology Co., Ltd.
 Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Scivita Medical Technology Co., Ltd. operates as a medical device company. It engages in the research and development, manufacturing, and commercialization of optical diagnosis and treatment medical devices. The firm’s products include 3D Visualization system and 4K Urtal HD Endoscope System. The company was founded on October 28, 2016 by Yi Zhang and To Chin and is headquartered in Suzhou, China. | Chairman | 22/06/2021 |
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 17/07/2020 |
Anciens postes connus de Xin Sun
| Sociétés | Poste | Fin |
|---|---|---|
| LUYE PHARMA GROUP LTD. | Director/Board Member | 06/12/2023 |
Affinity Equity Partners (HK) Ltd.
 Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Corporate Officer/Principal | - |
Formation de Xin Sun
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Duke University | Graduate Degree |
| Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LUYE PHARMA GROUP LTD. | Health Technology |
| SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Finance |
Scivita Medical Technology Co., Ltd.
Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Scivita Medical Technology Co., Ltd. operates as a medical device company. It engages in the research and development, manufacturing, and commercialization of optical diagnosis and treatment medical devices. The firm’s products include 3D Visualization system and 4K Urtal HD Endoscope System. The company was founded on October 28, 2016 by Yi Zhang and To Chin and is headquartered in Suzhou, China. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
